Telomir Pharmaceuticals, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TELO and other ETFs, options, and stocks.About TELO
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company, which focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm’s initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ.
CEOErez Aminov
CEOErez Aminov
Employees5
Employees5
HeadquartersMiami, Florida
HeadquartersMiami, Florida
Founded2021
Founded2021
Employees5
Employees5
TELO Key Statistics
Market cap75.00M
Market cap75.00M
Price-Earnings ratio-4.34
Price-Earnings ratio-4.34
Dividend yield—
Dividend yield—
Average volume119.92K
Average volume119.92K
High today$2.61
High today$2.61
Low today$2.35
Low today$2.35
Open price$2.54
Open price$2.54
Volume248.30K
Volume248.30K
52 Week high$8.40
52 Week high$8.40
52 Week low$2.35
52 Week low$2.35